491 Lane

"Agence France-Presse reporting, Blackwatch has once again benefited all mankind for the third time now after tackling the field of cancer and Alzheimer's disease by using bionic organ transplantation as an alternative to human organ transplantation. Its biomedical department announced today it has once again made an innovational breakthrough in stem cell technology and the cost of the 'Age-reversal Treatment' will once again be made affordable. The price is expected to go down from the market price set two years ago of 200,000 U.S. dollars to an average of 30,000 to 50,000 U.S. dollars.

"The cost of the 'Age-reversal Treatment' once cost upwards of a million dollars for each person. It only took six years for Blackwatch to fulfill the promise they once made that the 'Age-reversal Treatment' will be streamlined and commercialized to a price range that can cater to regular citizens.